Iridex (IRIX) Cost of Revenue (2010 - 2026)

Iridex's Cost of Revenue history runs 17 years deep, the most recent figure standing at $7.1 million for Q2 2026.

• On a quarterly basis, Cost of Revenue rose 3.17% year-over-year to $7.1 million in Q2 2026; TTM through Apr 2026 was $33.7 million, a 17.28% increase from a year earlier, with the FY2026 full-year figure at $33.4 million, up 14.68% from the prior year.
• Cost of Revenue declined to $7.1 million in Q2 2026 per IRIX's latest filing, from $9.2 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $17.0 million in Q1 2022 and bottomed at $6.8 million in Q1 2025.
• The 5-year median for Cost of Revenue is $7.5 million (2023), against an average of $8.2 million.
• Across the five-year window, Cost of Revenue sank 49.83% in 2022 and jumped 30.06% in 2026, its largest moves.
• Year by year, Cost of Revenue stood at $8.5 million in 2022, then fell by 11.23% to $7.6 million in 2023, then decreased by 6.11% to $7.1 million in 2024, then climbed by 19.14% to $8.5 million in 2025, then retreated by 16.68% to $7.1 million in 2026.
• Per Business Quant, the three latest IRIX Cost of Revenue figures stand at $7.1 million (Q2 2026), $9.2 million (Q1 2026), and $8.5 million (Q3 2025).